Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Prescription medicine · generic available

Orphenadrine citrate, aspirin and caffeine

Drug class: Nonsteroidal Anti-inflammatory Drug, Platelet Aggregation Inhibitor, Central Nervous System Stimulant, Methylxanthine

The FDA’s “Established Pharmacologic Class”: the group of medicines that work in a similar way.

Official FDA data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the drug label, the NDC Directory, Drugs@FDA, recall reports and the drug shortage list. Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Orphenadrine citrate, aspirin and caffeine key facts

Drug class
Nonsteroidal Anti-inflammatory Drug
Used for
Norgesic TM (orphenadrine citrate, aspirin and caffeine 25 mg/ 385 mg/ 30 mg) Tablets are indicated in: Symptomatic relief of mild to moderate pain of acute musculoskeletal disorders. (source)
Prescription or over the counter
Prescription (Rx)
Generic available
Yes
Latest FDA recall
None listed

Sources: FDA label (January 8, 2026); FDA NDC Directory (November 13, 2026); FDA enforcement reports (November 10, 2026). Not medical advice.

Quick answers

What is Orphenadrine citrate, aspirin and caffeine used for?
The FDA-approved label (Norgesic, Galt Pharmaceuticals, LLC, January 8, 2026) says: “Norgesic TM (orphenadrine citrate, aspirin and caffeine 25 mg/ 385 mg/ 30 mg) Tablets are indicated in: Symptomatic relief of mild to moderate pain of acute musculoskeletal disorders. The orphenadrine component is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
What are the side effects of Orphenadrine citrate, aspirin and caffeine?
The “Adverse Reactions” section of the FDA label (Norgesic, Galt Pharmaceuticals, LLC, January 8, 2026) begins: “Side effects of Norgesic TM Tablets are those seen with aspirin and caffeine or those usually associated with mild anti-cholinergic agents. These may include tachycardia, palpitation, urinary hesitancy or retention, dry mouth, blurred vision, dilation of the pupil, increased intraocular tension, weakness, nausea, vomiting, headache, dizziness, constipation, drowsiness, and rarely, urticaria and other dermatosis.” … This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Does Orphenadrine citrate, aspirin and caffeine have a boxed warning?
No. None of the 5 FDA labels we found for this medicine has a boxed warning.
Is there a shortage of Orphenadrine citrate, aspirin and caffeine?
No current shortage is listed by the FDA for the products of this medicine (FDA data from November 13, 2026).
Has Orphenadrine citrate, aspirin and caffeine been recalled?
No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
Who makes Orphenadrine citrate, aspirin and caffeine?
3 companies list prescription products of Orphenadrine citrate, aspirin and caffeine in the FDA NDC Directory, including Galt Pharmaceuticals, LLC, Atland Pharmaceuticals, LLC and Poly Pharmaceuticals, Inc.

What Orphenadrine citrate, aspirin and caffeine is used for

Quoted from the “Indications and Usage” section of the FDA-approved label.

Norgesic TM (orphenadrine citrate, aspirin and caffeine 25 mg/ 385 mg/ 30 mg) Tablets are indicated in: Symptomatic relief of mild to moderate pain of acute musculoskeletal disorders. The orphenadrine component is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. …

— FDA label: Norgesic, Galt Pharmaceuticals, LLC, effective January 8, 2026. Read the full label on DailyMed →

Label quoted: the one for the most common form (tablet, oral), Norgesic, Galt Pharmaceuticals, LLC; it covers 1 product in the FDA NDC Directory. The side effects, interactions, dosage and pregnancy quotes below come from this same label.

The FDA has 5 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

Boxed warning

A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.

The label quoted above has no boxed warning.

0 of 5 FDA labels for this medicine have a boxed warning.

Orphenadrine citrate, aspirin and caffeine side effects

Quoted from the “Adverse Reactions” section of the FDA-approved label. Tell your doctor about any side effect that worries you.

Side effects of Norgesic TM Tablets are those seen with aspirin and caffeine or those usually associated with mild anti-cholinergic agents. These may include tachycardia, palpitation, urinary hesitancy or retention, dry mouth, blurred vision, dilation of the pupil, increased intraocular tension, weakness, nausea, vomiting, headache, dizziness, constipation, drowsiness, and rarely, urticaria and other dermatosis.

Read more of this section

Infrequently, an elderly patient may experience some degree of confusion. Mild central excitation and occasional hallucinations may be observed. These mild side effects can usually be eliminated by reduction in dosage. One case of aplastic anemia associated with the use of orphenadrine citrate, aspirin and caffeine has been reported. No causal relationship has been established. Rare G.I. hemorrhage due to aspirin content may be associated with the administration of Norgesic TM Tablets. Some patients may experience transient episodes of light-headedness, dizziness or syncope.

— FDA label: Norgesic, Galt Pharmaceuticals, LLC, effective January 8, 2026. Read the full label on DailyMed →

Orphenadrine citrate, aspirin and caffeine dosage

Quoted from the “Dosage and Administration” section of the FDA-approved label. Your own dose is the one your doctor prescribes: do not change it on your own.

Norgesic TM Tablets: Adults 1 to 2 tablets 3 to 4 times daily.

— FDA label: Norgesic, Galt Pharmaceuticals, LLC, effective January 8, 2026. Read the full label on DailyMed →

When Orphenadrine citrate, aspirin and caffeine should not be used

Quoted from the “Contraindications” section of the FDA-approved label.

Because of the mild anticholinergic effect of orphenadrine, Norgesic TM Tablets should not be used in patients with glaucoma, pyloric or duodenal obstruction, achalasia, prostatic hypertrophy or obstructions at the bladder neck. Norgesic TM Tablets are also contraindicated in patients with myasthenia gravis and in patients known to be sensitive to aspirin or caffeine. The drug is contraindicated in patients who have demonstrated a previous hypersensitivity to the drug.

— FDA label: Norgesic, Galt Pharmaceuticals, LLC, effective January 8, 2026. Read the full label on DailyMed →

Forms and how it is given

Dosage formsTablet · Tablet, multilayer
RouteOral
Prescription products5 in the FDA NDC Directory
Brand namesNorgesic, Norgesic Forte, Orphengesic Forte

Companies that list this medicine

Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.

FDA approval history

  • ANDA: Abbreviated New Drug Application: how a generic version is approved.

Generic approvals (1)

Shortage status

The FDA drug shortage list does not show these products.

FDA Drug Shortages database →

Recalls

No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.

Official identifiers

RxCUI (RxNorm)994528, 994530, 994535, 994537, 994539
SPL set ID of the quoted labelbe2761bc-e537-4039-846a-2ffa3d8b2afc
FDA labels (SPL)5
FDA applications1 ANDA
Active ingredients (FDA)ASPIRIN / CAFFEINE / ORPHENADRINE

Next steps

Sources

  1. FDA-approved label on DailyMed (National Library of Medicine) — Norgesic, Galt Pharmaceuticals, LLC, effective January 8, 2026; via openFDA, FDA data exported November 13, 2026, retrieved November 14, 2026
  2. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  3. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026
  5. Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026

openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →

Report an error → · Information for medicine makers